Table 2. Female patients' perception and awareness of isotretinoin.
| Perception and awareness | No | % |
| Indication for isotretinoin | ||
| Severe nodular forms of acne resistant to regular treatment | 229 | 63.8% |
| Acne with oily skin with or without pores | 83 | 23.1% |
| Acne on the cheek | 10 | 2.8% |
| All forms of Acne | 37 | 10.3% |
| The daily maximum dose of isotretinoin | ||
| 10 to 20 mg | 90 | 25.1% |
| 30 to 40 mg | 125 | 34.8% |
| 50 to 60 mg | 39 | 10.9% |
| More than 70 mg | 3 | .8% |
| Don't know | 102 | 28.4% |
| The teratogenic effect is SE | ||
| Yes | 326 | 90.8% |
| No | 12 | 3.3% |
| Don't know | 21 | 5.8% |
| Have you ever heard of the Saudi Food and Drug Authority's (SFDA) Pregnancy Prevention Program (PPP) that established guidelines for isotretinoin use among females of reproductive age group (15-49 years)? | ||
| Yes | 112 | 31.2% |
| No | 247 | 68.8% |